Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Avery Dennison CorpAVY · Entity 3410 | Director · President & CEO | March 01, 2026 | March 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Avery Dennison Corp
Report date March 01, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 73,351 |
Ending reported balance
After 2026-03-01 transaction · row 10
10 source rows · reconciled sequenceRow 1 · 2026-03-01 · Exercise / conversion · Acquired 1,824 · Balance 66,968 Row 2 · 2026-03-01 · Tax withholding · Disposed 544 · Balance 66,424 Row 3 · 2026-03-01 · Exercise / conversion · Acquired 1,382 · Balance 67,806 Row 4 · 2026-03-01 · Tax withholding · Disposed 412 · Balance 67,394 Row 5 · 2026-03-01 · Exercise / conversion · Acquired 3,033 · Balance 70,427 Row 6 · 2026-03-01 · Tax withholding · Disposed 1,146 · Balance 69,281 Row 7 · 2026-03-01 · Exercise / conversion · Acquired 4,854 · Balance 74,135 Row 8 · 2026-03-01 · Tax withholding · Disposed 2,370 · Balance 71,765 Row 9 · 2026-03-01 · Exercise / conversion · Acquired 3,100 · Balance 74,865 Row 10 · 2026-03-01 · Tax withholding · Disposed 1,514 · Balance 73,351 |
| 2026 RSU AwardSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2030-03-01 | Direct | 16,622 |
Reported balance
After 2026-03-01 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-03-01 · Grant · Acquired 16,622 · Balance 16,622 F1: Restricted stock units (RSUs) vest 25% on each of the first, second, third and fourth anniversaries of the grant date. Each RSU represents a contingent right to receive one share of common stock. |
| 2026 PU AwardSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2029-03-01 | Direct | 24,033 |
Reported balance
After 2026-03-01 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2026-03-01 · Grant · Acquired 24,033 · Balance 24,033 F2: Performance units (PUs) vest, at the end of fiscal year 2028, provided certain performance objectives are met as determined by the Compensation Committee in February 2029. Each PU represents a contingent right to receive one share of common stock. |
| 2022 MSU AwardSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-03-01 | Direct | 0 |
Reported balance
After 2026-03-01 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2026-03-01 · Exercise / conversion · Disposed 1,824 · Balance 0 F3: Shares reflect the vesting of the fourth tranche of MSUs granted in February 2022 at 92% of target based on our absolute total stockholder return in excess of 10% during the 2022-2025 performance period, plus dividend equivalents accrued during the period. |
| 2023 MSU AwardSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-03-01 | Direct | 1,364 |
Reported balance
After 2026-03-01 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2026-03-01 · Exercise / conversion · Disposed 1,382 · Balance 1,364 F4: Shares reflect the vesting of the third tranche of MSUs granted in March 2023 at 96% of target based on our absolute total stockholder return during the 2023-2025 performance period, plus dividend equivalents accrued during the period. |
| 2024 MSU AwardSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2028-03-01 | Direct | 6,353 |
Reported balance
After 2026-03-01 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2026-03-01 · Exercise / conversion · Disposed 3,033 · Balance 6,353 F5: Shares reflect the vesting of the second tranche of MSUs granted in March 2024 at 92% of target based on our absolute total stockholder return during the 2024-2025 performance period, plus dividend equivalents accrued during the period. |
| 2025 MSU AwardSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2029-03-01 | Direct | 15,170 |
Reported balance
After 2026-03-01 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2026-03-01 · Exercise / conversion · Disposed 4,854 · Balance 15,170 F6: Shares reflect the vesting of the first tranche of MSUs granted in March 2025 at 94% of target based on our absolute total stockholder return during the 2025 performance period, plus dividend equivalents accrued during the period. |
| 2023 PU AwardSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-03-01 | Direct | 0 |
Reported balance
After 2026-03-01 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2026-03-01 · Exercise / conversion · Disposed 3,100 · Balance 0 F7: Shares reflect the vesting of PUs granted in March 2023 at 56% of target, based 50% on our cumulative economic value added of 0% of target and 50% on our relative total stockholder return of 112% of target. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units (RSUs) vest 25% on each of the first, second, third and fourth anniversaries of the grant date. Each RSU represents a contingent right to receive one share of common stock.
F2: Performance units (PUs) vest, at the end of fiscal year 2028, provided certain performance objectives are met as determined by the Compensation Committee in February 2029. Each PU represents a contingent right to receive one share of common stock.
F3: Shares reflect the vesting of the fourth tranche of MSUs granted in February 2022 at 92% of target based on our absolute total stockholder return in excess of 10% during the 2022-2025 performance period, plus dividend equivalents accrued during the period.
F4: Shares reflect the vesting of the third tranche of MSUs granted in March 2023 at 96% of target based on our absolute total stockholder return during the 2023-2025 performance period, plus dividend equivalents accrued during the period.
F5: Shares reflect the vesting of the second tranche of MSUs granted in March 2024 at 92% of target based on our absolute total stockholder return during the 2024-2025 performance period, plus dividend equivalents accrued during the period.
F6: Shares reflect the vesting of the first tranche of MSUs granted in March 2025 at 94% of target based on our absolute total stockholder return during the 2025 performance period, plus dividend equivalents accrued during the period.
F7: Shares reflect the vesting of PUs granted in March 2023 at 56% of target, based 50% on our cumulative economic value added of 0% of target and 50% on our relative total stockholder return of 112% of target.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2017 Filed Feb 27, 2017 19:47 UTC | Avery Dennison Corp AVY · Entity 3410 | Exercise / conversion2014 MSU Award · Derivative | 2,145 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008548 · form4.xml · derivative · entry 12 STANDER DEON · CIK 0001681362 · VP/General Manager, RBIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,278 Underlying: Common Stock · 2,145 shares Expires 2018-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Shares reflect the vesting of the third tranche of market leveraged stock units granted in February 2014 at 156% of target based on our absolute total shareholder return during 2014-2016, plus dividend equivalents accrued during the period. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 19:47 UTC | Avery Dennison Corp AVY · Entity 3410 | Exercise / conversion2013 MSU Award · Derivative | 3,399 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008548 · form4.xml · derivative · entry 11 STANDER DEON · CIK 0001681362 · VP/General Manager, RBIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,399 shares Expires 2017-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares reflect the vesting of the fourth tranche of market leveraged stock units granted in February 2013 at 200% of target based on our absolute total shareholder return during 2013-2016, plus dividend equivalents accrued during the period. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 19:47 UTC | Avery Dennison Corp AVY · Entity 3410 | Tax withholdingCommon Stock | 1,255 | $80.21 | $100,663.55 |
DisclosureSEC source: 0001127602-17-008548 · form4.xml · nonDerivative · entry 10 STANDER DEON · CIK 0001681362 · VP/General Manager, RBIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,998 Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 19:47 UTC | Avery Dennison Corp AVY · Entity 3410 | Exercise / conversionCommon Stock | 2,670 | $80.21 | $214,160.70 |
DisclosureSEC source: 0001127602-17-008548 · form4.xml · nonDerivative · entry 9 STANDER DEON · CIK 0001681362 · VP/General Manager, RBIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 19:47 UTC | Avery Dennison Corp AVY · Entity 3410 | Tax withholdingCommon Stock | 426 | $80.21 | $34,169.46 |
DisclosureSEC source: 0001127602-17-008548 · form4.xml · nonDerivative · entry 8 STANDER DEON · CIK 0001681362 · VP/General Manager, RBIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,583 Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 19:47 UTC | Avery Dennison Corp AVY · Entity 3410 | Exercise / conversionCommon Stock | 905 | $80.21 | $72,590.05 |
DisclosureSEC source: 0001127602-17-008548 · form4.xml · nonDerivative · entry 7 STANDER DEON · CIK 0001681362 · VP/General Manager, RBIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,009 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 19:47 UTC | Avery Dennison Corp AVY · Entity 3410 | Tax withholdingCommon Stock | 1,012 | $80.21 | $81,172.52 |
DisclosureSEC source: 0001127602-17-008548 · form4.xml · nonDerivative · entry 6 STANDER DEON · CIK 0001681362 · VP/General Manager, RBIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,104 Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 19:47 UTC | Avery Dennison Corp AVY · Entity 3410 | Exercise / conversionCommon Stock | 2,152 | $80.21 | $172,611.92 |
DisclosureSEC source: 0001127602-17-008548 · form4.xml · nonDerivative · entry 5 STANDER DEON · CIK 0001681362 · VP/General Manager, RBIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 19:47 UTC | Avery Dennison Corp AVY · Entity 3410 | Tax withholdingCommon Stock | 1,009 | $80.21 | $80,931.89 |
DisclosureSEC source: 0001127602-17-008548 · form4.xml · nonDerivative · entry 4 STANDER DEON · CIK 0001681362 · VP/General Manager, RBIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,964 Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 19:47 UTC | Avery Dennison Corp AVY · Entity 3410 | Exercise / conversionCommon Stock | 2,145 | $80.21 | $172,050.45 |
DisclosureSEC source: 0001127602-17-008548 · form4.xml · nonDerivative · entry 3 STANDER DEON · CIK 0001681362 · VP/General Manager, RBIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 19:47 UTC | Avery Dennison Corp AVY · Entity 3410 | Tax withholdingCommon Stock | 1,598 | $80.21 | $128,175.58 |
DisclosureSEC source: 0001127602-17-008548 · form4.xml · nonDerivative · entry 2 STANDER DEON · CIK 0001681362 · VP/General Manager, RBIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,828 Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 19:47 UTC | Avery Dennison Corp AVY · Entity 3410 | Exercise / conversionCommon Stock | 3,399 | $80.21 | $272,633.79 |
DisclosureSEC source: 0001127602-17-008548 · form4.xml · nonDerivative · entry 1 STANDER DEON · CIK 0001681362 · VP/General Manager, RBIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.